期刊
ANNALS OF ONCOLOGY
卷 25, 期 8, 页码 1475-1484出版社
ELSEVIER
DOI: 10.1093/annonc/mdu123
关键词
ESMO; consensus; non-small-cell lung cancer; first line; second line; further lines
类别
资金
- European Society for Medical Oncology central funds
To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on Lung Cancer was held on 11-12 May 2013 in Lugano. A total of 35 experts met to address several questions on non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, first-line/second and further lines of treatment in advanced disease, early-stage disease and locally advanced disease. For each question, recommendations were made including reference to the grade of recommendation and level of evidence. This consensus paper focuses on first line/second and further lines of treatment in advanced disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据